The stock index rebounded at the bottom this week, but it still fell 1.77% as a whole, closing negative for four consecutive weeks; The Shenzhen Component Index fell 0.95% and the gem rose 1.81%.
This week’s institutional research enthusiasm is still tepid. Data show that from March 14 to March 18, only 79 listed companies in Shanghai and Shenzhen obtained institutional research, an increase of 4 over last week. Among them, 23 listed companies received more than 30 institutional research, and 6 listed companies received more than 70 institutional research.
Industrial machinery became the hottest sector this week. Industry data show that 10 listed companies in this sector have obtained institutional research, followed by electrical components and equipment, and 8 listed companies have obtained institutional research; In addition, six and four listed companies in the western medicine and biotechnology sectors respectively obtained institutional research this week.
Picture: Top 10 listed companies surveyed by institutions this week
This week, Changchun High And New Technology Industries (Group) Inc(000661) ( Changchun High And New Technology Industries (Group) Inc(000661) . SZ) was the most popular, attracting 230 institutions to participate in the survey, including 72 public funds, 14 insurance funds, 34 securities companies and 94 investment institutions.
Recently, Changchun High And New Technology Industries (Group) Inc(000661) released the 2021 annual report. The company achieved an annual operating revenue of 10.747 billion yuan, an increase of 25.30% year-on-year; The net profit attributable to the parent company was 3.757 billion yuan, a year-on-year increase of 23.33%; The net profit attributable to the parent company after deduction was 3.742 billion yuan, a year-on-year increase of 26.76%.
“The company’s revenue exceeded 10 billion yuan for the first time in history, basically in line with expectations, but the growth rate of net profit was slightly lower than market expectations.” Li Zhixin, an analyst at capital securities, said that the net profit did not meet expectations, which was mainly caused by multiple factors: first, the total R & D investment increased last year, reaching 1.09 billion yuan, accounting for more than 10% of revenue, of which 885 million yuan was expensed (81% of expensed proportion), with a year-on-year growth rate of 86.3%, affecting certain profits; Second, the Changchun Bcht Biotechnology Co(688276) performance of the core subsidiary declined greatly last year, which was mainly affected by the epidemic, and there were large asset impairment losses.
On March 17, Changchun High And New Technology Industries (Group) Inc(000661) organized institutional research. In addition to public funds such as e fund, Zhonggeng fund and Ruiyuan fund, well-known private placements such as Gaoling capital, Gaoyi assets and Jinglin assets also appeared in the research list.
Changchun High And New Technology Industries (Group) Inc(000661) ( Changchun High And New Technology Industries (Group) Inc(000661) . SZ) also explained the reasons for the decline in performance when accepting the investigation of the above institutions, and said that the impact of the current epidemic on production and operation is generally controllable. The number of new pediatric patients enrolled in the core subsidiary kinsay pharmaceutical in January increased by more than 50% year-on-year; In February, despite the influence of the Spring Festival, it still maintained an increase of more than 35%. The overall revenue of growth hormone products increased by more than 40%. At present, there is no clear price reduction arrangement for water needle products; At present, the long-acting water needle has begun to adjust the product price.
In addition to Changchun High And New Technology Industries (Group) Inc(000661) , Tianrun Industry Technology Co.Ltd(002283) ( Tianrun Industry Technology Co.Ltd(002283) . SZ) has also attracted the attention of institutions. This week, it received 112 investment institutions for research. There are many well-known private placements such as Panjing investment and yuanlesheng in the research list. In addition, 10 billion fund managers such as Liu Peng of BOCOM Schroder fund and Chen Pengyang of Boshi fund also appeared.
Tianrun Industry Technology Co.Ltd(002283) is the largest professional crankshaft manufacturer in China. Its business involves the development of internal combustion engine power parts, railway equipment and machine tool equipment.
In view of the impact of the rising price of raw materials on the gross profit margin, Tianrun Industry Technology Co.Ltd(002283) in the survey, the company’s direct raw materials account for about 56% of the whole cost. According to last year’s calculation, the annual rise in raw material costs affected the gross profit by about 2.3%, the rise in power costs affected the gross profit by about 0.3%, and the price of auxiliary raw materials also increased. In 2021, the gross profit decreased slightly by 0.7% and the net interest rate remained at about 11.45%. Through mandatory cost reduction and efficiency improvement, the company must reduce all controllable costs by 5% every year. It is estimated that the cost and gross profit in 2022 will remain at the level of 2021, but if the raw materials continue to rise sharply, the company will be affected.
